Press Releases

Susan G. Komen® honors Dr. Matthew Ellis with Brinker AwardOct 3, 2019
Dr. Matthew Ellis has been awarded the Susan G. Komen® Brinker Award for Scientific Distinction in Clinical Research.
Cell roles in immunotherapy-resistant breast cancer profiledAug 26, 2019
To better understand the specific roles different immune cell types play, a multi-institutional team profiled the immune cell composition of multiple murine models and clinical datasets of triple negative breast cancers.
Cancer Prevention & Research Institute of Texas awards grantsFeb 22, 2019
The Cancer Prevention and Research Institute of Texas has awarded a combined $9,266,605 for seven projects in breast cancer, childhood cancers, T Cell therapy and lung cancer prevention.
Discovery explains breast cancer cells’ ability to adapt, surviveJan 28, 2019
A team led by researchers at Baylor College of Medicine has discovered that breast cancer cells can shift between two forms of the cell surface molecule CD44, CD44s and CD44v.
DPYSL3 an outlier gene in triple-negative breast cancerNov 26, 2018
Researchers have developed an entirely new therapeutic hypothesis on how to treat an aggressive form of triple-negative breast cancer.
Repurposing FDA-approved drugs to fight breast cancerNov 16, 2018
A team of researchers shows Food and Drug Administration (FDA)-approved compounds can stop cancer growth and can potentially lead to the discovery of drugs in a way that is quicker and less expensive than traditional drug development strategies.
Novel strategy may reduce breast cancer bone metastasisNov 12, 2018
Uncovering a novel mechanism that promotes growth of breast cancer bone metastasis has revealed a potential Achilles' heel for these cancer cells. 
Dr. Alastair Thompson to lead breast surgical oncologyOct 22, 2018
Dr. Alastair Thompson is bringing his expertise Baylor as the new section chief of breast surgery in the Michael E. DeBakey Department of Surgery, Division of Surgical Oncology, and co-director of the Lester and Sue Smith Breast Center.
Grant supports research into racial, ethnic health disparitiesOct 3, 2018
The National Cancer Institute has awarded $6.3 million dollars Baylor researchers to create new tools to help researchers to better understand the biological causes behind racial and ethnic health disparities in prostate and breast cancers.
Research leads to rare ER+ breast cancer mutations insightSep 4, 2018
Researchers conducted the largest analysis to date to establish associations between rare somatic mutations and prognosis in estrogen receptor positive (ER+) breast cancer
Estrogen receptor events linked to breast cancer metastasisAug 7, 2018
Researchers identify estrogen receptor alpha gene (ESR1) translocation events that drive not only therapeutic resistance, but also trigger ER+ breast cancer cells to metastasize.
Baylor launches community breast cancer education eventJun 27, 2018
Baylor College of Medicine has launched Breast Cancer Conversations, a quarterly educational event designed to inform the public about what’s new in breast cancer.
DNA repair defect may drive some cancer treatment resistanceMay 25, 2018
Researchers found that defects in selective DNA damage repair pathways can drive endocrine treatment resistance in a subset of estrogen receptor positive breast cancer patients.
Researchers awarded multiple Department of Defense grants in next frontier of breast cancer genomicsMay 24, 2018
The Department of Defense has awarded researchers at Baylor College of Medicine multiple grants to help better understand breast cancer genomics.
New promise found in treating triple negative breast cancerMar 26, 2018
A new study has identified a novel treatment strategy that may be effective for triple negative breast cancer patients.
G-quadruplex regulates breast cancer-associated geneDec 21, 2017
Researchers have now discovered a mechanism by which cells can regulate switching between the two proteins, opening options for the development of novel therapeutic strategies to control cancer growth in the future.
Dr. Jeffery Rosen honored for breast cancer research Dec 8, 2017
Dr. Jeffrey Rosen was awarded the American Association for Cancer Research (AACR) Distinguished Lecture in Breast Cancer Research at the San Antonio Breast Cancer Symposium.
Dr. Matthew Ellis named to Forbes’ “Physician Honor Roll"Dec 5, 2017
Dr. Matthew Ellis is one of 27 breast oncologists across the country being recognized by Forbes as an exemplary physician in the field of breast cancer oncology.
Lumpectomy, lift good combination for breast cancer patientsOct 17, 2017
An effort between a surgical oncologist and plastic surgeon can provide an opportunity for women diagnosed with breast cancer to not only have the lump removed, but also get a breast lift at the same time.
Baylor introduces new metastatic breast cancer programOct 9, 2017
Oct. 13 has been declared Metastatic Breast Cancer Day by the Senate of the State of Texas. In honor of this proclamation, Baylor College of Medicine is launching a new program aimed at fighting the disease.